comparemela.com

Latest Breaking News On - Natural sciences foundation of china - Page 1 : comparemela.com

Breathing Easy: New Study Declares Waste-to-Energy Plants a Low Health Risk

A recent study has highlighted the insignificant health hazards posed by the emissions from waste-to-energy (WtE) facilities in China s Bohai Rim. This investig

China
Tianjin
Bohai
Zhejiang
Wenchao-ma
Natural-sciences-foundation-of-china
Tianjin-university
Environment-health-on
Weather-research
Bohai-rim
California-puff
Hazard-indices

RepliCel Launches the Next Stage of a Research Project with the University of British Columbia to Build World-Class Hair Follicle Cell Data Map

RepliCel Launches the Next Stage of a Research Project with the University of British Columbia to Build World-Class Hair Follicle Cell Data Map ACCESSWIRE 11 May 2021, 20:05 GMT+10 Early identification of unique cell markers is expected to have valuable impact on patents, clinical efficacy, and manufacturing optimization VANCOUVER, BC / ACCESSWIRE / May 11, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ( RepliCel or the Company ) is pleased to announce it has now signed and launched a new collaborative research project agreement with the University of British Columbia ( UBC ) that enables the second stage of its cell marker research. The project is being co-led by RepliCel s Dr. Kevin McElwee and UBC s Professor Youwen Zhou.

Germany
New-york
United-states
Maine
Japan
Hong-kong
United-kingdom
Vancouver
British-columbia
Canada
China
Toronto

RepliCel Life Sciences, Inc.: RepliCel Launches the Next Stage of a Research Project with the University of British Columbia to Build World-Class Hair Follicle Cell Data Map

(1) Early identification of unique cell markers is expected to have valuable impact on patents, clinical efficacy, and manufacturing optimization VANCOUVER, BC / ACCESSWIRE / May 11, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ( RepliCel or the Company ) is pleased to announce it has now signed and launched a new collaborative research project agreement with the University of British Columbia ( UBC ) that enables the second stage of its cell marker research. The project is being co-led by RepliCel s Dr. Kevin McElwee and UBC s Professor Youwen Zhou. The project commenced in 2017, is designed to deliver a gene and protein expression map of healthy hair follicle cells expected to be critically important to improving key components of the manufacturing, regulatory, and clinical profile of RepliCel s cell therapy products.

Germany
New-york
United-states
Maine
Japan
Hong-kong
United-kingdom
Vancouver
British-columbia
Canada
China
Toronto

vimarsana © 2020. All Rights Reserved.